DAN HUNTING: Open Payments
NPI 1336710862 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 55 payments from 17 companies in 2025. Trend: 2023 $760 · 2024 $3,336 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $210 |
| PFIZER INC. | 10 | $178 |
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| Novartis Pharmaceuticals Corporation | 7 | $128 |
| Medtronic, Inc. | 2 | $86 |
| BridgeBio Pharma, Inc. | 2 | $58 |
| Amgen Inc. | 4 | $58 |
| SCPHARMACEUTICALS INC. | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: VYNDAQEL, VERQUVO, LEQVIO, FARXIGA, SYMPLICITY G3, Attruby, REPATHA, WAINUA.
Industry payments across ID — which companies pay providers there.
